natgillin/translations-raw huggingface dataset:
-Enlarged lymph glands (sometimes painful) -Increase in a type of white blood cell which may be associated with allergic reaction, disorder of blood clotting system -Heart rhythm problems including very fast heartbeat, very slow heartbeat, fainting -Depressed function of the adrenal gland -Problem with coordination -Swelling of the brain -Double vision pain and inflammation of the eyes and eyelids, involuntary movement of the eye -Decreased sensitivity to touch -Constipation, inflammation of upper small intestine, dyspepsia, pancreatitis, peritonitis -Gingivitis, -Swelling and inflammation of the tongue -Enlarged liver, hepatitis, liver failure, gallbladder disease, gallstones -Joint pain -Inflammation of the kidney, proteins in the urine -Abnormal electrocardiogram (ECG) -Blood chemistry changes
- spremembe izidov krvnih preiskav za spremljanje delovanja jeter
Rare side effects (occurring in at least 1 in 10,000 patients) are:
Občasni neželeni učinki (ki se pojavijo pri vsaj 1 od 1. 000 bolnikov) so:
- Inability to sleep
- oteklost možganov
-Hearing difficulties, ringing in the ears -Abnormal sense of taste
- dvojni vid, bolečina ter vnetje oči in vek, nehoteni gibi očesa
121 -Increase in muscle tone, muscle weakness caused by an abnormal immune system response -Abnormal brain function, Parkinson-like symptoms, convulsion -Sleepiness during infusion
- nenormalno delovanje možganov, simptomi, podobni Parkinsonovi bolezni, krči skeletnih mišic
Reactions during the infusion have occurred uncommonly with VFEND (including flushing, fever, sweating, increased heart rate and shortness of breath).
Občasno so se med infundiranjem zdravila VFEND pojavile reakcije (vključno z zardevanjem, zvišano telesno temperaturo, znojenjem, pospešenim srčnim utripom in težkim dihanjem).
If any of the side effects gets serious or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.
Če katerikoli neželeni učinek postane resen ali če opazite katerikoli neželen učinek, ki ni omenjen v tem navodilu, obvestite svojega zdravnika ali farmacevta.
Keep VFEND out of the reach and sight of children.
Zdravilo shranjujte nedosegljivo otrokom!
Do not use VFEND after the expiry date which is stated on the label.
Zdravila VFEND ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na ovojnini.
Once reconstituted, VFEND should be used immediately, but if necessary may be stored for up to 24 hours at 2°C - 8°C (in a refrigerator).
Ko je zdravilo VFEND pripravljeno (rekonstituirano), ga je treba uporabiti takoj, če pa je treba, se ga lahko shrani pri temperaturi med 2° C in 8° C (v hladilniku) za največ 24 ur.
Reconstituted VFEND needs to be diluted with a compatible infusion solution first before it is infused.
Tako pripravljeno zdravilo VFEND je treba pred infundiranjem razredčiti z združljivo infuzijsko raztopino.
(Please refer to the end of this leaflet for further information).
(Dodatne informacije najdete na koncu tega navodila.)
Each vial contains 200 mg voriconazole, equivalent to a 10 mg/ ml solution when reconstituted as directed by your hospital pharmacist or nurse (see the information at the end of this leaflet).
Kaj vsebuje zdravilo VFEND – Zdravilna učinkovina je vorikonazol. – Pomožna snov: sulfobutileter betaciklodekstrin natrij Ena viala vsebuje 200 mg vorikonazola, kar ustreza raztopini 10 mg/ ml, če jo bolnišnični farmacevt ali medicinska sestra pripravita po navodilu (glejte informacije na koncu navodila).
What VFEND looks like and contents of the pack
Izgled zdravila VFEND in vsebina pakiranja VFEND je pripravljen kot prašek za raztopino za infundiranje v stekleni viali za enkratno uporabo.
The information in this leaflet is about VFEND 200 mg powder for solution for infusion only.
Informacije v tem navodilu se nanašajo samo na prašek za raztopino za infudiranje VFEND.
For further information on VFEND 50 mg and 200 mg film-coated tablets or VFEND 40 mg/ ml powder for oral suspension, please see the User Package Leaflet for these products.
Za dodatne informacije o VFEND 50 mg in 200 mg filmsko obloženih tabletah ter VFEND 40 mg/ ml prašku za peroralno suspenzijo glejte navodila za uporabo teh zdravil.
Manufacturer
121 Imetnik dovoljenja za promet z zdravilom Pfizer Limited, Ramsgate Rd, Sandwich, Kent CT13 9NJ, Velika Britanija
Pfizer PGM, Zone Industrielle, 29 Route des Industries, 37530 Pocé-sur-Cisse, France.
Izdelovalec Pfizer PGM, Zone Industrielle, 29 route des Industries, 37530 Pocé- sur- Cisse, Francija
For any information about this medicinal product, please contact the local representative of the 122 Marketing Authorisation Holder:
Za vse morebitne nadaljnje informacije o tem zdravilu se lahko obrnete na predstavništvo imetnika dovoljenja za promet z zdravilom:
Slovenija Pfizer Luxembourg SARL Pfizer, podruž nica za svetovanje s področ ja farmacevtske dejavnosti, Ljubljana Tel: + 386/ 1/ 52 11 400
Tel: + 386/ 1/ 5211 400
Italia Pfizer Italia S. r. l.
122 Italia Pfizer Italia S. r. l.
This leaflet was last approved in {MM/ YYYY}.
{MM/ LLLL}
< ----------------------------------------------------------------------------------------------------------------- The following information is intended for medical or healthcare professionals only:
----------------------------------------------------------------------------------------------------------------------- Naslednje informacije so namenjene samo zdravstvenemu osebju:
Reconstitution and Dilution information  VFEND powder for solution for infusion needs to first be reconstituted with 19 ml of Water for Injections to obtain an extractable volume of 20 ml of clear concentrate containing 10 mg/ ml voriconazole.  Discard the VFEND vial if the vacuum does not pull the diluent into the vial.  It is recommended that a standard 20 ml (non-automated) syringe be used to ensure that the exact amount (19.0 ml) of Water for Injections is dispensed.  The required volume of the reconstituted concentrate is then added to a recommended compatible infusion solution listed below to obtain a final VFEND solution containing 0.5 to 5 mg/ ml of voriconazole.  This medicinal product is for single use only and any unused solution should be discarded and only clear solutions without particles should be used.  Not for administration as a bolus injection.  For storage information, please refer to Section 5 ‘ How to store VFEND’.
Zdravilo se ne sme aplicirati kot bolusna injekcija.  Glede informacij za shranjevanje glejte poglavje 5 "Shranjevanje zdravila VFEND". 
124 Required Volumes of 10 mg/ ml VFEND Concentrate
123 Potrebne prostornine za 10 mg/ ml VFEND koncentrata
Volume of VFEND Concentrate (10 mg/ ml) required for:
Prostornina VFEND koncentrata (10mg/ ml), potrebna za:
3 mg/ kg dose (number of vials) - - - - 9.0 ml (1) 10.5 ml (1) 12.0 ml (1) 13.5 ml (1) 15.0 ml (1) 16.5 ml (1) 18.0 ml (1) 19.5 ml (1) 21.0 ml (2) 22.5 ml (2) 24.0 ml (2) 25.5 ml (2) 27.0 ml (2) 28.5 ml (2) 30.0 ml (2)
(število vial) - - - - 9, 0 ml (1) 10, 5 ml (1) 12, 0 ml (1) 13, 5 ml (1) 15, 0 ml (1) 16. 5 ml (1) 18, 0 ml (1) 19, 5 ml (1) 21, 0 ml (2) 22, 5 ml (2) 24, 0 ml (2) 25, 5 ml (2) 27, 0 ml (2) 28, 5 ml (2) 30, 0 ml (2)
The reconstituted solution can be diluted with:
Pripravljeno (rekonstituirano) raztopino je mogoče razredčiti z:
The compatibility of VFEND with diluents other than listed above (or listed below under ‘ Incompatibilities’) is unknown.
Združljivost zdravila VFEND z drugimi tekočinami razen zgoraj naštetih (ali omenjenih spodaj pod "Inkompatibilnosti") ni znana.
Incompatibilities:
124 Inkompatibilnosti:
VFEND must not be diluted with 4.2% Sodium Bicarbonate Infusion.
Zdravila VFEND se ne sme redčiti s 4, 2% natrijevim bikarbonatom za infundiranje.
125 PACKAGE LEAFLET:
125 NAVODILO ZA UPORABO
VFEND 40 mg/ ml powder for oral suspension.
VFEND 40 mg/ ml prašek za peroralno suspenzijo vorikonazol
Voriconazole
- Navodilo shranite.
You may need to read it again.  If you have any questions, ask your doctor or pharmacist.  This medicine has been prescribed for you.
- Zdravilo je bilo predpisano vam osebno in ga ne smete dajati drugim.
How to store VFEND 6 Further information
Dodatne informacije
VFEND is used to treat serious fungal infections caused by Aspergillus, Scedosporium, Fusarium, fluconazole-resistant Candida, and candidaemia in patients with normal white blood cell counts.
VFEND se uporablja za zdravljenje hudih glivičnih okužb, ki jih povzročajo Aspergillus, Scedosporium, Fusarium in proti flukonazolu odporna Candida, ter za zdravljenje kandidemije pri bolnikih z nizkim številom belih krvnih celic.
Do not take VFEND:  if you are allergic to voriconazole or any of the other ingredients of VFEND
- če ste alergični na vorikonazol ali katerokoli sestavino zdravila VFEND.
 Terfenadine (used for allergy)  Astemizole (used for allergy)  Cisapride (used for stomach problems)  Pimozide (used for treating mental illness)  Quinidine (used for irregular heart beat)  Rifampicin (used for treating tuberculosis)  Carbamazepine (used to treat seizures)  Phenobarbital (used for severe insomnia and seizures)
terfenadin (uporablja se proti alergiji)  astemizol (uporablja se proti alergiji)  cisaprid (uporablja se proti težavam z želodcem)  pimozid (uporablja se za zdravljenje duševnih bolezni)  kinidin (uporablja se proti nerednemu srčnemu utripu)  rifampicin (uporablja se za zdravljenje tuberkuloze)  karbamazepin (uporablja se za zdravljenje napadov krčev) 
126  Ergot alkaloids (e. g. ergotamine, dihydroergotamine; used for migraine)  Sirolimus (used in transplant patients)  Ritonavir (used for treating HIV) in doses of 400mg and more twice daily  St John’ s Wort (herbal supplement)
126 fenobarbital (uporablja se proti hudi nespečnosti in napadom krčev)  alkaloidi ergot (npr. ergotamin, dihidroergotamin; uporabljajo se proti migreni)  sirolimus (uporablja se pri bolnikih po presaditvah organov)  ritonavir (uporablja se za zdravljenje okužbe s HIV) v odmerkih 400 mg in več, dvakrat na dan  šentjanževka (zdravilo rastlinskega izvora) 
Tell your doctor if you are taking any of the following medicines, as VFEND must not be taken if you are already taking any of these medicines (See also Section 2 above ‘ Do not take VFEND’):  Terfenadine (used for allergy)  Astemizole (used for allergy)  Carbamazepine (used to treat seizures)  Cisapride (used for stomach problems)  Pimozide (used for treating mental illness)  Quinidine (used for irregular heart beat)  Rifampicin (used for treating tuberculosis)  Phenobarbital (used for severe insomnia and seizures)  Ergot alkaloids (e. g. ergotamine, dihydroergotamine; used for migraine)  Sirolimus (used in transplant patients)  Ritonavir (used for treating HIV) in doses of 400 mg and more twice daily  St John’ s Wort (herbal supplement)
terfenadin (uporablja se proti alergiji)  astemizol (uporablja se proti alergiji)  karbamazepin (uporablja se za zdravljenje napadov krčev)  cisaprid (uporablja se proti težavam z želodcem)  pimozid (uporablja se za zdravljenje duševnih bolezni)  kinidin (uporablja se proti nerednemu srčnemu utripu)  rifampicin (uporablja se za zdravljenje tuberkuloze)  fenobarbital (uporablja se proti hudi nespečnosti in napadom krčev)  alkaloide ergot (npr. ergotamin, dihidroergotamin; uporabljajo se proti migreni)  sirolimus (uporablja se pri bolnikih po presaditvah organov)  ritonavir (uporablja se za zdravljenje okužbe s HIV) v odmerkih 400 mg in več, dvakrat na dan  šentjanževko (zdravilo rastlinskega izvora) 
Tell your doctor if you are taking any of the following medicines, as a dose adjustment or monitoring may be required to check that the medicines and/ or VFEND are still having the desired effect:  Warfarin and other anticoagulants (e. g. phenprocoumon, acenocoumarol; used to slow down clotting of the blood)  Ciclosporin (used in transplant patients)  Tacrolimus (used in transplant patients)  Sulphonylureas (e. g. tolbutamide, glipizide, and glyburide) (used for diabetes)  Statins (e. g. atorvastatin, simvastatin) (used for lowering cholesterol)  Benzodiazepines (e. g midazolam, triazolam) (used for severe insomnia and stress)  Omeprazole (used for treating ulcers)  Oral contraceptives (if you take VFEND whilst using oral contraceptives, you may get side effects such as nausea and menstrual disorders)  Vinca alkaloids (e. g. vincristine and vinblastine) (used in treating cancer)  Indinavir and other HIV protease inhibitors (used for treating HIV)  Non-nucleoside reverse transcriptase inhibitors (e. g. efavirenz, delavirdine, nevirapine) (used for treating HIV)
Svojemu zdravniku povejte, če jemljete katerokoli od naslednjih zdravil, ker bo morda potrebna prilagoditev odmerka ali nadziranje, da se preveri, ali imajo le- ta oziroma zdravilo VFEND še vedno želeni učinek: varfarin ali druge antikoagulante (npr. fenprokumon, acenokumarol; uporabljajo se za  upočasnitev strjevanja krvi) ciklosporin (uporablja se pri bolnikih po presaditvah organov)  takrolimus (uporablja se pri bolnikih po presaditvah organov)  sulfonilsečnine (npr. tolbutamid, glipizid in gliburid) (uporabljajo se za zdravljenje sladkorne  bolezni) statine (npr. atorvastatin, simvastatin) (uporabljajo se za zniževanje ravni holesterola)  benzodiazepine (npr. midazolam, triazolam) (uporabljajo se pri hudi nespečnosti in stresu)  omeprazol (uporablja se za zdravljenje razjed)  peroralne kontraceptive (če med jemanjem peroralnih kontraceptivov jemljete zdravilo VFEND,  se pri vas lahko pojavijo neželeni učinki, kot npr. slabost s siljenjem na bruhanje ali motnje menstruacije)
127  Methadone (used to treat heroin addiction)  Efavirenz (used for treating HIV) (some doses of efavirenz can NOT be taken at the same time as VFEND)  Alfentanil and other short acting opiates such as fentanyl and sufentanil (painkillers used for surgical procedures)  Non-steroidal anti-inflammatory drugs (e. g. ibuprofen, diclofenac) (used for treating pain and inflammation)
127 alkaloide rožnatega zimzelena (npr. vinkristin in vinblastin) (uporabljajo se za zdravljenje raka)  indinavir oz. druge zaviralce proteaz HIV (uporabljajo se za zdravljenje okužbe s HIV)  zaviralce nenukleozidne reverzne transkriptaze (npr. efavirenz, delavirdin, nevirapin) (uporabljajo  se za zdravljenje okužbe s HIV) metadon (uporablja se za zdravljenje heroinske odvisnosti)  efavirenz (uporablja se za zdravljenje okužbe s HIV) (določene odmerke efavirenza se NE sme  vzeti sočasno z zdravilom VFEND) alfentanil in druge kratkodelujoče opiate, npr. fentanil in sufentanil (zdravila proti bolečinam, ki  se uporabljajo pri operacijah) nesteroidna protivnetna zdravila (npr. ibuprofen, diklofenak) (uporabljajo se proti bolečini in za  zdravljenje vnetja)
VFEND suspension must be taken at least one hour before or two hours after a meal.
VFEND peroralno suspenzijo je treba vzeti vsaj eno uro pred jedjo ali dve uri po jedi.
VFEND suspension contains 0.54g sucrose per ml of suspension.
VFEND peroralna suspenzija vsebuje 0, 54 g saharoze v 1 ml suspenzije.
HOW TO TAKE VFEND Always take VFEND exactly as your doctor has told you.
KAKO JEMATI ZDRAVILO VFEND
You should check with your doctor or pharmacist if you are not sure.
Pri jemanju zdravila VFEND natančno upoštevajte zdravnikova navodila.
Your doctor will determine your dose depending on your weight and the type of infection you have.
Če ste negotovi, se posvetujte z zdravnikom ali s farmacevtom.
128 The usual dose for adults (including elderly patients) is as follows:
128 Odmerek, ki ga potrebujete, bo zdravnik določil glede na vašo telesno maso in vrsto okužbe.
Oral suspension Patients 40 kg and above Patients less than 40 kg
bolniki z manj kot 40 kg
Dose for the first 24 hours (Loading Dose)
odmerek v prvih 24 urah
400 mg (10 ml) every 12 hours for the first 24 hours
(10 ml) vsakih 12 ur v
200 mg (5 ml) every 12 hours for the first 24 hours
200 mg (5 ml) vsakih 12 ur v prvih
100 mg (2.5 ml) twice a day
100 mg (2, 5 ml) dvakrat na dan
The doctor may decide to decrease the dose if you have mild to moderate cirrhosis.  The usual dose for children aged 2 to less than 12 years is 200 mg twice daily.  VFEND should not be given to children younger than 2 years of age.  Teenagers (aged 12 to 16 years) should be dosed as for adults.
Običajni odmerek za otroke, stare od 2 do manj kot 12 let, je 200 mg dvakrat na dan. 
Take your suspension at least one hour before, or two hours after a meal.
Zdravila VFEND ne smejo dobiti otroci, mlajši od 2 let.
Patients with a weakened immune system or those with difficult infections may require long-term treatment to prevent the infection from returning.
Pri bolnikih z oslabelim imunskim sistemom ali s težkimi okužbami utegne biti za preprečitev ponovitve okužbe potrebno dolgotrajno zdravljenje.
VFEND suspension should not be mixed with any other medication.
VFEND peroralne suspenzije ne smete mešati z nobenim drugim zdravilom.
Take your bottle of VFEND suspension with you.
S seboj vzemite plastenko VFEND peroralne suspenzije.
Do not take a double dose to make up for the forgotten dose.
Ne vzemite dvojnega odmerka, če ste pozabili prejšnji odmerek.
When VFEND treatment is stopped by your doctor you should not experience any effects.
Potem ko po zdravnikovem naročilu končate zdravljenje z zdravilom VFEND, ne bi smeli občutiti nobenih posledic.
It is recommended that your pharmacist constitutes VFEND suspension before giving it to you.
Vendar morate, če jemljete zdravila, ki vsebujejo ciklosporin ali takrolimus, zdravnika na to opozoriti, ker bo treba prilagoditi njihov odmerek.
129 1.
129 Navodilo za pripravo suspenzije:
Measure 23 ml of water by filling the measuring cup (included in the carton) to the top of the
S pomočjo merice (ki je priložena v škatli) odmerite 23 ml vode, tako da napolnite merico do vrha označene črte.
marked line then pour the water into the bottle.
Dodajte vodo v plastenko.
Using the cup measure another 23 ml water and add this to the bottle. You should always add a total of 46 ml (2 x 23 ml) of water irrespective of the dose you are taking.
Vedno morate dodati vseh 46 ml (2 x 23 ml) vode, ne glede na odmerek, ki ga jemljete.
Write the date of expiry of the constituted suspension on the bottle label (the shelf-life of the constituted suspension is 14 days).
Na nalepko napišite rok uporabnosti že pripravljene suspenzije (rok uporabnosti pripravljene suspenzije je 14 dni).
Please see instructions below before using VFEND suspension.
Preden uporabite VFEND suspenzijo, preberite spodnja navodila:
Turn the bottle back upright with the oral syringe still in place.
Obrnite plastenko z brizgo ponovno v pokončni položaj.
Cleaning and storing the syringe:
hranjenje brizge:
-Fever -Rash -Nausea, vomiting, diarrhoea -Headache -Swelling of the extremities -Stomach pains
- slabost s siljenjem na bruhanje, bruhanje, driska
-Flu-like symptoms, sinusitis, chills, weakness -Anaemia, low numbers of cells called platelets that help the blood to clot, low numbers of some types of white blood cells or of all types of blood cells, red or purple discoloration of the skin which may be caused by low platelet count, other blood cell changes -Low blood sugar, low blood potassium -Anxiety, depression, tingling, confusion, dizziness, agitation, trembling, hallucinations and other nervous symptoms -Low blood pressure, inflammation of a vein (which may be associated with the formation of a blood clot) -Breathing difficulty, chest pain, fluid accumulation in the lungs -Jaundice, redness of the skin -Swelling of the lips or face -Allergic reactions (sometimes severe), including widespread blistering rash and skin peeling, severe skin reaction following exposure to light or sun -Itchiness -Hair loss -Back pain
- odpoved ledvic, kri v urinu, spremembe izidov krvnih preiskav za spremljanje delovanja ledvic
131 -Kidney failure, blood in the urine, changes in blood tests of kidney function -Changes in blood tests of liver function
131
-Enlarged lymph glands (sometimes painful) -Increase in a type of white blood cell which may be associated with allergic reaction, disorder of blood clotting system -Heart rhythm problems including very fast heartbeat, very slow heartbeat, fainting -Depressed function of the adrenal gland -Problem with coordination -Swelling of the brain -Double vision pain and inflammation of the eyes and eyelids, involuntary movement of the eye -Decreased sensitivity to touch -Constipation, inflammation of upper small intestine, dyspepsia, pancreatitis, peritonitis -Gingivitis, -Swelling and inflammation of the tongue -Enlarged liver, hepatitis, liver failure, gallbladder disease, gallstones -Joint pain -Inflammation of the kidney, proteins in the urine -Abnormal electrocardiogram (ECG) -Blood chemistry changes
- spremembe kemijske sestave krvi
Rare side effects (occurring in at least 1 in 10,000 patients) are:
Redki neželeni učinki (ki se pojavijo pri vsaj 1 od 10. 000 bolnikov) so:
-Hearing difficulties, ringing in the ears -Abnormal sense of taste -Increase in muscle tone, muscle weakness caused by an abnormal immune system response -Abnormal brain function, Parkinson-like symptoms, convulsion
- nenormalno delovanje možganov, simptomi, podobni Parkinsonovi bolezni, krči skeletnih mišic
If any of these side effects persist or are troublesome, please tell your doctor.
Če katerikoli neželeni učinek postane resen ali če je katerikoli od teh neželenih učinkov trdovraten ali moteč, povejte svojemu zdravniku.
If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.
Če opazite katerikoli neželen učinek, ki ni omenjen v tem navodilu, obvestite svojega zdravnika ali farmacevta.
Powder for oral suspension: store at 2°C - 8°C (in a refrigerator) before constitution.
Prašek za peroralno suspenzijo: pred pripravo shranjujte pri temperaturi med 2° C in 8° C (v hladilniku).
For the constituted suspension:
Pripravljeno suspenzijo:
Do not store above 30°C.
Shranjujte pri temperaturi do 30° C.
Store in the original container Keep the container tightly closed.
Vsebnik shranjujte tesno zaprt.
Ask your pharmacist how to 132 dispose of medicines no longer required.
132 Zdravila ne smete vreči v odpadne vode ali gospodinjske odpadke.
What VFEND contains:
Kaj vsebuje zdravilo VFEND
- The active substance is voriconazole.
- Zdravilna učinkovina je vorikonazol.
Each bottle contains 45 g of powder providing 70 ml of
Ena plastenka vsebuje 45 g praška, iz katerega dobimo po
suspension when constituted with water as recommended.
pripravi z vodo 70 ml suspenzije.
(See section 3 ‘ How to take VFEND’).
En ml pripravljene suspenzije vsebuje 40 mg vorikonazola (glejte poglavje 3 "Kako jemati zdravilo VFEND").
- The other ingredients are sucrose; silica colloidal; titanium dioxide; xanthan gum; sodium
- Pomožne snovi so: saharoza, koloidni silicijev dioksid, titanov dioksid, ksantanski gumi, natrijev
citrate; sodium benzoate; citric acid; natural orange flavour.
citrat, natrijev benzoat, citronska kislina in naravna aroma pomaranče.
What VFEND looks like and contents of the pack VFEND is supplied as a white to off-white powder for oral suspension providing a white to off-white, orange flavoured suspension when constituted with water.
Izgled zdravila VFEND in vsebina pakiranja VFEND je na voljo v obliki belega do belkastega praška za peroralno suspenzijo, iz katerega dobimo po pripravi z vodo belo do belkasto suspenzijo z okusom pomaranče.
The information in this leaflet is about VFEND 40 mg/ ml powder for oral suspension only.
Informacije v tem navodilu se nanašajo samo na VFEND 40 mg/ ml prašek za peroralno suspenzijo.
For further information on VFEND 50 mg and 200 mg film-coated tablets or VFEND 200 mg powder for solution for infusion, please see the User Package Leaflets for these products.
Za dodatne informacije o VFEND 50 mg in 200 mg filmsko obloženih tabletah in VFEND 200 mg prašku za raztopino za infundiranje glejte navodila za uporabo teh zdravil.
Manufacturer
Imetnik dovoljenja za promet z zdravilom Pfizer Limited, Ramsgate Rd, Sandwich, Kent CT13 9NJ, Velika Britanija
133 Ελλάδα Pfizer Hellas A. E.
133 Ελλάδα Pfizer Hellas A. E.
Viagra is a medicine that contains the active substance sildenafil.
Viagra je zdravilo, ki vsebujejo zdravilno učinkovino sildenafil.